This inventor holds 1 USPTO granted patent. Top assignee: Incyte Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Ho Yong Lim
Introduction
Ho Yong Lim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work has led to the development of a unique patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Ho Yong Lim holds a patent for "Pharmaceutical Combinations for Treating Tumor Comprising Anti-CD19 Antibody and Natural Killer Cell." This patent represents a significant advancement in cancer treatment, focusing on harnessing the body's immune system to combat tumor cells effectively. He has 1 patent to his name, reflecting his commitment to innovation in the pharmaceutical industry.
Career Highlights
Throughout his career, Ho Yong Lim has been associated with Incyte Corporation, a leading biopharmaceutical company. His work at Incyte has allowed him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development efforts.
Collaborations
Some of his notable coworkers include Jung Hyun Her and Mi Young Jung. Their collaborative efforts have further enhanced the research environment at Incyte Corporation, fostering innovation and creativity in the pursuit of effective cancer treatments.
Conclusion
Ho Yong Lim's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as an influential inventor. His patent and collaborations demonstrate his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile